This page lists the SEC filings reported by HHLR ADVISORS, LTD..
Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
---|---|---|---|---|---|---|
SC 13G/A | 2022-07-11 | HHLR ADVISORS, LTD. | iQIYI, Inc. | 149,075,912 | 5.0% | EDGAR |
SC 13G/A | 2022-02-14 | HHLR ADVISORS, LTD. | Root, Inc. | 7,087,405 | 5.2% | EDGAR |
SC 13G/A | 2022-02-14 | HHLR ADVISORS, LTD. | Yatsen Holding Ltd | 322,610,654 | 18.0% | EDGAR |
SC 13G/A | 2022-02-14 | HHLR ADVISORS, LTD. | Apellis Pharmaceuticals, Inc. | - | 0.0% | EDGAR |
SC 13G/A | 2022-02-14 | HHLR ADVISORS, LTD. | Beam Therapeutics Inc. | - | 0.0% | EDGAR |
SC 13G/A | 2022-02-14 | HHLR ADVISORS, LTD. | LEAP THERAPEUTICS, INC. | - | 0.0% | EDGAR |
SC 13G/A | 2022-02-14 | HHLR ADVISORS, LTD. | TAL Education Group | - | 0.0% | EDGAR |
SC 13G/A | 2022-02-14 | HHLR ADVISORS, LTD. | MINISO Group Holding Ltd | 1,009,290 | 0.1% | EDGAR |
SC 13G/A | 2022-02-14 | HHLR ADVISORS, LTD. | Aligos Therapeutics, Inc. | 2,365,064 | 5.6% | EDGAR |
SC 13G/A | 2022-02-14 | HHLR ADVISORS, LTD. | Futu Holdings Ltd | 2 | - | EDGAR |
SC 13G/A | 2022-02-14 | HHLR ADVISORS, LTD. | KE Holdings Inc. | 89,085,195 | 3.3% | EDGAR |
SC 13G | 2022-02-14 | HHLR ADVISORS, LTD. | Agora, Inc. | 20,000,000 | 5.8% | EDGAR |
SC 13G | 2022-02-14 | HHLR ADVISORS, LTD. | Cytek Biosciences, Inc. | 8,757,030 | 6.5% | EDGAR |
SC 13G | 2022-02-14 | HHLR ADVISORS, LTD. | On Holding AG | 15,973,750 | 5.3% | EDGAR |
SC 13D/A | 2021-09-27 | HHLR ADVISORS, LTD. | I-Mab | 16,520,560 | 9.3% | EDGAR |
SC 13G | 2021-09-27 | HHLR ADVISORS, LTD. | Smart Share Global Ltd | 62,627,893 | 14.7% | EDGAR |
SC 13D/A | 2021-07-19 | HHLR ADVISORS, LTD. | Enstar Group LTD | - | 0.0% | EDGAR |
SC 13D/A | 2021-06-24 | HILLHOUSE CAPITAL ADVISORS, LTD. | I-Mab | 19,050,560 | 11.3% | EDGAR |
SC 13D/A | 2021-04-22 | HILLHOUSE CAPITAL ADVISORS, LTD. | China Biologic Products Holdings, Inc. | 0 | 0.0% | EDGAR |
SC 13D/A | 2021-03-25 | HILLHOUSE CAPITAL ADVISORS, LTD. | I-Mab | 19,050,560 | 11.3% | EDGAR |
- Form 13F-HR
- The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
- Form SC 13D/G
- Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
- Form 3, 4, and 5
- Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.